Scarica l'app Stockscreener
34.28
1.15%
0.39
Dopo l'orario di chiusura:
34.28
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HRMY Giù?
Forum
Previsione
Precedente Chiudi:
$33.89
Aprire:
$33.48
Volume 24 ore:
2.25M
Relative Volume:
2.99
Capitalizzazione di mercato:
$1.96B
Reddito:
$681.88M
Utile/perdita netta:
$122.63M
Rapporto P/E:
13.93
EPS:
2.46
Flusso di cassa netto:
$220.18M
1 W Prestazione:
+5.84%
1M Prestazione:
+4.54%
6M Prestazione:
+18.99%
1 anno Prestazione:
+6.99%
Intervallo 1D:
$33.48
$34.97
Intervallo di 1 settimana:
$32.18
$34.97
Portata 52W:
$28.14
$41.61
Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile
Nome
Harmony Biosciences Holdings Inc
Settore
Industria
Telefono
(484) 539-9800
Indirizzo
630 W GERMANTOWN PIKE, PLYMOUTH MEETING
Confronta HRMY con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HRMY
Harmony Biosciences Holdings Inc
|
34.28 | 1.96B | 681.88M | 122.63M | 220.18M | 2.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-17 | Iniziato | H.C. Wainwright | Buy |
| 2024-10-10 | Ripresa | Raymond James | Outperform |
| 2024-09-10 | Iniziato | UBS | Buy |
| 2024-06-21 | Iniziato | Citigroup | Buy |
| 2024-01-02 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-09-25 | Downgrade | Goldman | Neutral → Sell |
| 2023-09-07 | Iniziato | Berenberg | Buy |
| 2023-04-20 | Iniziato | BofA Securities | Neutral |
| 2022-10-14 | Aggiornamento | Janney | Neutral → Buy |
| 2022-10-14 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-08-03 | Downgrade | Jefferies | Buy → Hold |
| 2022-07-13 | Downgrade | Goldman | Buy → Neutral |
| 2022-07-07 | Iniziato | Mizuho | Buy |
| 2022-04-14 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-12-01 | Iniziato | Oppenheimer | Outperform |
| 2021-11-04 | Iniziato | Raymond James | Outperform |
| 2021-09-23 | Iniziato | Needham | Buy |
| 2021-03-29 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-09-14 | Iniziato | Goldman | Neutral |
| 2020-09-14 | Iniziato | Jefferies | Buy |
| 2020-09-14 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Harmony Biosciences Holdings Inc Borsa (HRMY) Ultime notizie
Research Analysts Offer Predictions for HRMY FY2024 Earnings - MarketBeat
State Street Corp Has $49.62 Million Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat
Comprehensive Market Analysis of Latest Published 9 Rare Genetic Disorders Reports | DelveInsight - GlobeNewswire Inc.
HARMONY BIOSCIENCES TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE - BioSpace
HC Wainwright & Co. Initiates Coverage of Harmony Biosciences Holdings (HRMY) with Buy Recommendation - MSN
Harmony Biosciences (NASDAQ:HRMY) Shares Up 3.6%Here's Why - MarketBeat
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Sees Large Decrease in Short Interest - MarketBeat
Harmony Biosciences (NASDAQ:HRMY) Earns Buy Rating from Analysts at HC Wainwright - MarketBeat
How To Trade (HRMY) - Stock Traders Daily
HighTower Advisors LLC Has $3.20 Million Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat
HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES - The Eastern Progress Online
HRMY Makes Notable Cross Below Critical Moving Average - Nasdaq
HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFEREN - GuruFocus.com
Harmony Biosciences to Join Fireside Chat at Oppenheimer Rare Disease Summit - MSN
Jacobs Levy Equity Management Inc. Has $8.98 Million Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat
Verition Fund Management LLC Acquires 34,524 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat
HRMY: 3 Emerging Biotech Stocks Developing Breakthrough Therapies - StockNews.com
HRMYHarmony Biosciences Holdings, Inc. Latest Stock News & Market Updates - StockTitan
Trend Tracker for (HRMY) - Stock Traders Daily
HARMONY BIOSCIENCES TO PARTICIPATE IN OPPENHEIMER MOVERS IN RARE DISEASE SUMMIT - Lelezard
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives $47.00 Consensus Target Price from Analysts - MarketBeat
Top 5 US Stocks To Buy In December 2024 - Investing.com
Martingale Asset Management L P Purchases 14,946 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Bought by Citigroup Inc. - MarketBeat
Harmony Biosciences (NASDAQ:HRMY) Trading Down 3.1%Time to Sell? - MarketBeat
Harmony Biosciences Hits the Stage: Engaging Investors at Top 2024 Conferences - MSN
HRMY (Harmony Biosciences Holdings) Market Cap : $1,987.0 Mil (As of Nov. 26, 2024) - GuruFocus.com
Massachusetts Financial Services Co. MA Buys 140,690 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat
StoneX Group Inc. Acquires New Shares in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat
Victory Capital Management Inc. Sells 15,966 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat
Pacer Advisors Inc. Sells 581,273 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat
Harmony Biosciences to Present at Citi and Piper Sandler Healthcare Conferences | HRMY Stock News - StockTitan
Harmony Biosciences Reports Record Revenue and Plans Expansion in CNS Treatments - MSN
HRMY (Harmony Biosciences Holdings) GF Value Rank : 4 (As of Nov. 20, 2024) - GuruFocus.com
Principal Financial Group Inc. Sells 19,654 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat
Quest Partners LLC Acquires 20,689 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat
First Week of July 2025 Options Trading For Harmony Biosciences Holdings (HRMY) - Nasdaq
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Sees Significant Drop in Short Interest - MarketBeat
14,396 Shares in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Purchased by CWA Asset Management Group LLC - MarketBeat
Harmony Biosciences’ Common Stock Offering - Global Legal Chronicle
Harmony Biosciences: sNDA Of WAKIX Brings Additional Value Inflection Points (NASDAQ:HRMY) - Seeking Alpha
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Harmony Biosciences director Antonio Gracias sells $139m in stock - Investing.com India
Marshman Fund Trust II sells $139.39 million in Harmony Biosciences stock - Investing.com
Harmony Biosciences director Antonio Gracias sells $139m in stock By Investing.com - Investing.com UK
AlphaCentric Advisors LLC Has $3.88 Million Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat
There May Be Some Bright Spots In Harmony Biosciences Holdings' (NASDAQ:HRMY) Earnings - Yahoo Canada Finance
Harmony Biosciences Holdings Inc Azioni (HRMY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):